This excerpt taken from the TPTX 8-K filed Jun 8, 2006.
Evelyn Graham, Chief Operating Officer
Prior to joining TorreyPines Therapeutics, Ms. Graham was Executive Director, Development Operations at Purdue Pharma. In this capacity, she managed global operations supporting a portfolio of marketed and early to late-stage pain compounds. Ms. Graham has 19 years clinical development experience and a proven track record of establishing and running development operations for pharmaceutical and contract research organizations. Ms. Graham was Senior Vice President of Business Development at Ingenix Pharmaceutical Services, a division of UnitedHealth Group (UHG), and Vice President of Clinical Operations at Worldwide Clinical Trials, prior to its acquisition by UHG. Her pharmaceutical experience includes positions in operations management, healthcare utilization, and organizational planning at Bayer Corporation and Wyeth Pharmaceuticals (formerly Ayerst Laboratories).